Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02793765
Title Docetaxel Followed by Provenge in Metastatic Prostate Cancer
Recruitment Withdrawn
Gender male
Phase Phase II
Variant Requirements No
Sponsors The University of Texas Health Science Center, Houston
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.